Results 161 to 170 of about 21,046 (260)

Cytotoxic Activity of <i>Boswellia serrata</i> Roxb. Essential Oil and Acetyl-11-Keto-β-Boswellic Acid (AKBA) on Hepatocellular Carcinoma Cells: In Vitro and In Silico Study. [PDF]

Int J Mol Sci
Alarcon-Aguilar FJ, Torres-Chacón DL, Suárez-Alonso A, Estrada-Soto SE, Gómez-Quiroz LE, Flores Sáenz JLE, Vega Ávila E, Blancas Flores G, Giacoman Martínez A, Mora Ramiro B, Almanza-Pérez JC.   +10 more
europepmc   +1 more source

DHX15 affects AML1‐ETO9a splicing together with HNRNPL, RBM33 in AML1‐ETO‐positive acute myeloid leukaemia

British Journal of Haematology, Volume 209, Issue 3, Page 964-977, September 2026.
Moderate DHX15, HNRNPL and RBM33 expression drives predominant AML1‐ETO mRNA production, while elevated expression of them promotes generating more AE9a mRNA (Aspartic acid ‐ Glutamic acid ‐ Alanine ‐ Aspartic acid sequence)(messenger ribonucleic acid).
Qiao Liu, Xuechun Wang, Jiqiang Fan, Yi Zheng, Luya Ye, Wenhan Chang, Xianglei Chen, Yuanhua Cai, Xiaolin Lai, Yang Li, Lili Pan, Xiaofan Li, RenJang Lin, Shaoyuan Wang   +13 more
wiley   +1 more source

Usnic acid induces apoptosis and inhibits cell migration and invasion in hepatocarcinoma cells: in vitro and in silico analysis. [PDF]

BMC Complement Med Ther
Mutlu D.
europepmc   +1 more source

Targeting Egfr‐Mediated Cell Proliferation and Lipid Metabolism Separation Effectively Accelerate Liver Regeneration

Cell Proliferation, Volume 59, Issue 9, September 2026.
AREG coordinates cell proliferation and lipid metabolism reprogramming during liver regeneration and targeting lipid metabolism can promote liver regeneration. ABSTRACT Hepatocyte proliferation restores liver mass after partial hepatectomy (PHx), but the metabolic cost of this process remains unclear.
Yuelei Hu, Shifei Song, Ruilin Wang, Ni An, Jinmei Diao, Yuguo Chen, Juan Liu, Guoyue Lv   +7 more
wiley   +1 more source

Costs and health outcomes of liver transplantation for hepatocellular carcinoma: a scoping review. [PDF]

Cost Eff Resour Alloc
Palacios-Barahona U, Rendón LGT, Berruecos YA, Fonseca A, Rojas-Gualdrón D.   +4 more
europepmc   +1 more source

Impact of Preoperative Cardiac Screening Modality on Cardiovascular Outcomes After Liver Transplantation

Clinical Transplantation, Volume 40, Issue 9, September 2026.
ABSTRACT Introduction Cardiovascular (CV) disease is a leading cause of morbidity and mortality after liver transplantation (LT). Coronary computed tomography angiography (CCTA) has increasingly replaced stress testing (ST) for CV risk assessment in LT candidates with intermediate‐to‐high CV risk, although comparative evidence remains limited.
Giuseppe Esposito, Marcella Manicardi, Niccolò Bonini, Stefano Di Sandro, Marco Vitolo, Fabrizio Di Benedetto, Giuseppe Boriani, Gian Piero Guerrini   +7 more
wiley   +1 more source

In Vitro Effects of Anaesthetic Compounds on a Panel of Solid Tumour Cell Lines—An Exploratory Study

Journal of Cellular and Molecular Medicine, Volume 30, Issue 18, September 2026.
ABSTRACT Anaesthetic agents are essential for surgical procedures, yet their potential role on tumour cell biology remains incompletely understood. Emerging evidence suggests that these compounds can act both as protumor and antitumor agents, influencing cellular processes such as proliferation, migration and cell death mechanisms.
Olga Grajdieru, Alexandru Cristian Sabo, Adrian Bogdan Tigu, Andrei Ivancuta, Cristian Silviu Moldovan, Andrada Uhl, Miruna Cristina Ungurenasu, Andrada‐Ioana Balmez, Ada Moisescu, Simina Pîrv, Madalina Nistor, Ximena‐Maria Muresan, Diana Cenariu, Ciprian Tomuleasa, Catalin Constantinescu   +14 more
wiley   +1 more source

[Clinical and Imaging Features in Patients with Cirrhosis and Hepatocellular Carcinoma at a Tertiary Hospital in Córdoba] [PDF]

Rev Fac Cien Med Univ Nac Cordoba
Oliva V, Muiño G, Orozco S, Saad EJ.
europepmc   +1 more source

Autophagy in MASLD: A Metabolic and Precision Medicine Perspective

Liver International, Volume 46, Issue 9, September 2026.
ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD) is the most common chronic liver condition worldwide and a major contributor to cirrhosis and hepatocellular carcinoma (HCC). While metabolic triggers such as obesity and insulin resistance are key drivers of MASLD, growing evidence has identified defects in intracellular quality
Alessandra Cazzaniga, Silvia Frigo, Alessandro Cherubini, Eniada Rrapaj, Luca Valenti   +4 more
wiley   +1 more source

[Retracted] Effects of TLR4 gene silencing on the proliferation and apotosis of hepatocarcinoma HEPG2 cells. [PDF]

Oncol Lett
Liu Y, Li T, Xu Y, Xu E, Zhou M, Wang B, Shen J.   +6 more
europepmc   +1 more source